Patents by Inventor Kayla Hardwick

Kayla Hardwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cannabis Ubiquitin Promoter
    Publication number: 20240084317
    Abstract: Provided herein is the identification and use of the Cannabis Ubiquitin promoter and its use in promoting the expression of one or more heterologous nucleic acid fragments in a constitutive manner in Cannabis plants. The invention further discloses com-e positions, polynucleotide constructs, transformed host cells, plants and seeds containing the recombinant construct with the promoter, and methods for preparing and using the same.
    Type: Application
    Filed: October 9, 2020
    Publication date: March 14, 2024
    Inventors: Gregory Peel, Kayla Hardwick, Jessica Staha, Alisha Holloway
  • Varin markers
    Patent number: 11920187
    Abstract: Provided herein is the identification of markers associated with THCV, THCVA, CBDV, CBDVA, CBGV, or CBGVA production in Cannabis plants and their use in selecting Cannabis plants having modified THCV, THCVA, CBDV, CBDVA, CBGV, or CBGVA activity. The markers are useful for breeding plants having modified varin activity, including elevated THCV levels, by obtaining nucleic acids, detecting one or more markers that indicate modified varin activity, and establishing plant lines having such characteristics.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: March 5, 2024
    Assignee: Phylos Bioscience, Inc.
    Inventors: Erica Bakker, Alisha Holloway, Kayla Hardwick
  • VARIN PROFILES
    Publication number: 20230255159
    Abstract: The present invention discloses cannabis plants, seeds and other plant parts, tissue cultures, and products having elevated levels of varin molecules, including tetrahydrocannabivarin (THCV) and/or cannabidivarin (CBDV). Each of THCV and CBDV have unique pharmacological profiles with distinct molecular targets, and can be used as agents for antiepileptic or anticonvulsant activity, obesity-associated glucose intolerance, appetite suppression, anxiety management for PTSD, diabetic neuropathy, or major neuropathic and pain related pathologies.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 17, 2023
    Applicant: Phylos Bioscience, Inc.
    Inventors: Alisha Holloway, Jared Reynbery, Kayla Hardwick, John McFerson, Nishan Karassik, Erica Bakker
  • Varin Markers
    Publication number: 20230014963
    Abstract: Provided herein is the identification of markers associated with THCV, THCVA, CBDV, CBDVA, CBGV, or CBGVA production in Cannabis plants and their use in selecting Cannabis plants having modified THCV, THCVA, CBDV, CBDVA, CBGV, or CBGVA activity. The markers are useful for breeding plants having modified varin activity, including elevated THCV levels, by obtaining nucleic acids, detecting one or more markers that indicate modified varin activity, and establishing plant lines having such characteristics.
    Type: Application
    Filed: August 24, 2022
    Publication date: January 19, 2023
    Inventors: Erica Bakker, Alisha Holloway, Kayla Hardwick